NYSE:PHR - New York Stock Exchange, Inc. - US71944F1066 - Common Stock - Currency: USD
NYSE:PHR (2/21/2025, 1:19:44 PM)
28.435
-0.03 (-0.09%)
The current stock price of PHR is 28.435 USD. In the past month the price increased by 4.56%. In the past year, price increased by 17.51%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.17 | 36.70B | ||
DOCS | DOXIMITY INC-CLASS A | 56.51 | 13.57B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.27B | ||
CERT | CERTARA INC | 33.9 | 2.13B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.98B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 15.08 | 1.84B | ||
SDGR | SCHRODINGER INC | N/A | 1.67B | ||
EVH | EVOLENT HEALTH INC - A | 16.26 | 1.25B | ||
HSTM | HEALTHSTREAM INC | 50.57 | 999.58M | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 971.88M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.66 | 772.58M | ||
SLP | SIMULATIONS PLUS INC | 79.46 | 638.56M |
Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The company is headquartered in Wilmington, Delaware and currently employs 1,438 full-time employees. The company went IPO on 2019-07-18. The firm's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The firm also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The firm's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
PHREESIA INC
1521 Concord Pike, Suite 301 Pmb 221
Wilmington DELAWARE 27601 US
CEO: Chaim Indig
Employees: 1438
Company Website: https://www.phreesia.com
Investor Relations: https://ir.phreesia.com/
Phone: 18886547473
The current stock price of PHR is 28.435 USD. The price decreased by -0.09% in the last trading session.
The exchange symbol of PHREESIA INC is PHR and it is listed on the New York Stock Exchange, Inc. exchange.
PHR stock is listed on the New York Stock Exchange, Inc. exchange.
19 analysts have analysed PHR and the average price target is 32.13 USD. This implies a price increase of 12.99% is expected in the next year compared to the current price of 28.435. Check the PHREESIA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PHREESIA INC (PHR) has a market capitalization of 1.65B USD. This makes PHR a Small Cap stock.
PHREESIA INC (PHR) currently has 1438 employees.
PHREESIA INC (PHR) has a support level at 28.45 and a resistance level at 29.84. Check the full technical report for a detailed analysis of PHR support and resistance levels.
The Revenue of PHREESIA INC (PHR) is expected to grow by 20.1% in the next year. Check the estimates tab for more information on the PHR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PHR does not pay a dividend.
PHREESIA INC (PHR) will report earnings on 2025-03-12, after the market close.
PHREESIA INC (PHR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.12).
The outstanding short interest for PHREESIA INC (PHR) is 4.55% of its float. Check the ownership tab for more information on the PHR short interest.
ChartMill assigns a technical rating of 9 / 10 to PHR. When comparing the yearly performance of all stocks, PHR is one of the better performing stocks in the market, outperforming 89.33% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to PHR. The financial health of PHR is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months PHR reported a non-GAAP Earnings per Share(EPS) of -1.12. The EPS increased by 20% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -22.03% | ||
ROE | -32.52% | ||
Debt/Equity | 0.04 |
ChartMill assigns a Buy % Consensus number of 85% to PHR. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 6.9% and a revenue growth 20.1% for PHR